BARK INC (BARK)

US68622E1047 - Common Stock

1.97  +0.08 (+4.23%)

After market: 1.98 +0.01 (+0.51%)

Fundamental Rating

4

Overall BARK gets a fundamental rating of 4 out of 10. We evaluated BARK against 120 industry peers in the Specialty Retail industry. BARK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, BARK is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

BARK had negative earnings in the past year.
BARK had a positive operating cash flow in the past year.
In the past 5 years BARK always reported negative net income.
In multiple years BARK reported negative operating cash flow during the last 5 years.

1.2 Ratios

BARK has a worse Return On Assets (-10.05%) than 77.12% of its industry peers.
BARK's Return On Equity of -24.53% is on the low side compared to the rest of the industry. BARK is outperformed by 65.25% of its industry peers.
Industry RankSector Rank
ROA -10.05%
ROE -24.53%
ROIC N/A
ROA(3y)-14.5%
ROA(5y)-22.57%
ROE(3y)-31.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 61.95%, BARK belongs to the top of the industry, outperforming 91.53% of the companies in the same industry.
In the last couple of years the Gross Margin of BARK has grown nicely.
The Profit Margin and Operating Margin are not available for BARK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.09%
GM growth 5Y1.95%

6

2. Health

2.1 Basic Checks

BARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BARK has less shares outstanding
The number of shares outstanding for BARK has been reduced compared to 5 years ago.
Compared to 1 year ago, BARK has an improved debt to assets ratio.

2.2 Solvency

BARK has an Altman-Z score of 1.23. This is a bad value and indicates that BARK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.23, BARK is doing worse than 72.88% of the companies in the same industry.
BARK has a debt to FCF ratio of 3.72. This is a good value and a sign of high solvency as BARK would need 3.72 years to pay back of all of its debts.
BARK's Debt to FCF ratio of 3.72 is fine compared to the rest of the industry. BARK outperforms 67.80% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that BARK is not too dependend on debt financing.
BARK has a Debt to Equity ratio (0.32) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.72
Altman-Z 1.23
ROIC/WACCN/A
WACC9.8%

2.3 Liquidity

BARK has a Current Ratio of 2.42. This indicates that BARK is financially healthy and has no problem in meeting its short term obligations.
BARK has a better Current ratio (2.42) than 86.44% of its industry peers.
BARK has a Quick Ratio of 1.49. This is a normal value and indicates that BARK is financially healthy and should not expect problems in meeting its short term obligations.
BARK has a Quick ratio of 1.49. This is amongst the best in the industry. BARK outperforms 83.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.49

5

3. Growth

3.1 Past

BARK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.92%, which is quite impressive.
Looking at the last year, BARK shows a decrease in Revenue. The Revenue has decreased by -2.98% in the last year.
BARK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.69% yearly.
EPS 1Y (TTM)76.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y8.99%
Revenue growth 5Y20.69%
Sales Q2Q%2.5%

3.2 Future

Based on estimates for the next years, BARK will show a very strong growth in Earnings Per Share. The EPS will grow by 33.99% on average per year.
Based on estimates for the next years, BARK will show a quite strong growth in Revenue. The Revenue will grow by 10.06% on average per year.
EPS Next Y78.67%
EPS Next 2Y49.7%
EPS Next 3Y41.37%
EPS Next 5Y33.99%
Revenue Next Year1.04%
Revenue Next 2Y5.43%
Revenue Next 3Y7.58%
Revenue Next 5Y10.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BARK. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 74.28, the valuation of BARK can be described as expensive.
65.25% of the companies in the same industry are cheaper than BARK, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.69. BARK is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 74.28

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BARK is valued a bit cheaper than the industry average as 61.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 31.75
EV/EBITDA N/A

4.3 Compensation for Growth

BARK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BARK's earnings are expected to grow with 41.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.7%
EPS Next 3Y41.37%

0

5. Dividend

5.1 Amount

No dividends for BARK!.
Industry RankSector Rank
Dividend Yield N/A

BARK INC

NYSE:BARK (1/3/2025, 8:21:37 PM)

After market: 1.98 +0.01 (+0.51%)

1.97

+0.08 (+4.23%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners40.41%
Inst Owner Change4.43%
Ins Owners17.69%
Ins Owner Change3.47%
Market Cap342.68M
Analysts84
Price Target2.68 (36.04%)
Short Float %10.05%
Short Ratio12.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1457.16%
Min EPS beat(2)43.44%
Max EPS beat(2)2870.89%
EPS beat(4)4
Avg EPS beat(4)753.83%
Min EPS beat(4)0.97%
Max EPS beat(4)2870.89%
EPS beat(8)6
Avg EPS beat(8)378.07%
EPS beat(12)9
Avg EPS beat(12)243.93%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)0.74%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)0.74%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5%
PT rev (3m)15.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.86%
EPS NY rev (1m)0%
EPS NY rev (3m)17.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 74.28
P/S 0.7
P/FCF 31.75
P/OCF 18.48
P/B 2.77
P/tB 2.97
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.03
Fwd EY1.35%
FCF(TTM)0.06
FCFY3.15%
OCF(TTM)0.11
OCFY5.41%
SpS2.81
BVpS0.71
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.05%
ROE -24.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.95%
FCFM 2.21%
ROA(3y)-14.5%
ROA(5y)-22.57%
ROE(3y)-31.36%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.09%
GM growth 5Y1.95%
F-Score7
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.72
Debt/EBITDA N/A
Cap/Depr 62.82%
Cap/Sales 1.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 1.49
Altman-Z 1.23
F-Score7
WACC9.8%
ROIC/WACCN/A
Cap/Depr(3y)259.1%
Cap/Depr(5y)262.4%
Cap/Sales(3y)3.32%
Cap/Sales(5y)2.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y78.67%
EPS Next 2Y49.7%
EPS Next 3Y41.37%
EPS Next 5Y33.99%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y8.99%
Revenue growth 5Y20.69%
Sales Q2Q%2.5%
Revenue Next Year1.04%
Revenue Next 2Y5.43%
Revenue Next 3Y7.58%
Revenue Next 5Y10.06%
EBIT growth 1Y38.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.68%
EBIT Next 3Y36.84%
EBIT Next 5Y29.52%
FCF growth 1Y109.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.11%
OCF growth 3YN/A
OCF growth 5YN/A